Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 120

1.

Lipid Biomarkers in Alzheimer's Disease.

Zarrouk A, Debbabi M, Bezine M, Karym EM, Badreddine A, Rouaud O, Moreau T, Cherkaoui-Malki M, El Ayeb M, Nasser B, Hammami M, Lizard G.

Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426. [Epub ahead of print]

PMID:
28474568
2.

Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study.

Fougère B, de Souto Barreto P, Goisser S, Soriano G, Guyonnet S, Andrieu S, Vellas B; MAPT Study Group..

Clin Nutr. 2017 Apr 12. pii: S0261-5614(17)30128-0. doi: 10.1016/j.clnu.2017.04.005. [Epub ahead of print]

PMID:
28442236
3.

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group..

Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27.

PMID:
28359749
4.

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Lanoiselée HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, Richard AC, Pasquier F, Rollin-Sillaire A, Martinaud O, Quillard-Muraine M, de la Sayette V, Boutoleau-Bretonniere C, Etcharry-Bouyx F, Chauviré V, Sarazin M, le Ber I, Epelbaum S, Jonveaux T, Rouaud O, Ceccaldi M, Félician O, Godefroy O, Formaglio M, Croisile B, Auriacombe S, Chamard L, Vincent JL, Sauvée M, Marelli-Tosi C, Gabelle A, Ozsancak C, Pariente J, Paquet C, Hannequin D, Campion D; collaborators of the CNR-MAJ project..

PLoS Med. 2017 Mar 28;14(3):e1002270. doi: 10.1371/journal.pmed.1002270. eCollection 2017 Mar.

5.

Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage.

Béjot Y, Grelat M, Delpont B, Durier J, Rouaud O, Osseby GV, Hervieu-Bègue M, Giroud M, Cordonnier C.

Neurology. 2017 Mar 7;88(10):985-990. doi: 10.1212/WNL.0000000000003681. Epub 2017 Feb 3.

PMID:
28159886
6.

Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease.

Rouch L, Cestac P, Cool C, Helmer C, Dartigues JF, Berr C, Rouaud O, Vellas B, Andrieu S; REAL-FR Study Group and the 3C Study Group..

Curr Alzheimer Res. 2017;14(3):255-267. doi: 10.2174/1567205013666161108114850.

PMID:
27829336
7.

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.

Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group..

J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.

8.

The Early Indicators of Functional Decrease in Mild Cognitive Impairment.

Kubicki A, Fautrelle L, Bourrelier J, Rouaud O, Mourey F.

Front Aging Neurosci. 2016 Aug 12;8:193. doi: 10.3389/fnagi.2016.00193. eCollection 2016.

9.

Gender effect on driving cessation in pre-dementia and dementia phases: results of the 3C population-based study.

Marie Dit Asse L, Fabrigoule C, Helmer C, Laumon B, Berr C, Rouaud O, Auriacombe S, Lafont S.

Int J Geriatr Psychiatry. 2016 Aug 23. doi: 10.1002/gps.4565. [Epub ahead of print]

PMID:
27550076
10.

Seizures in dominantly inherited Alzheimer disease.

Zarea A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, Rousseau S, Borden A, Pariente J, Le Ber I, Pasquier F, Formaglio M, Martinaud O, Rollin-Sillaire A, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Ceccaldi M, Gabelle A, Chamard L, Blanc F, Sellal F, Paquet C, Campion D, Hannequin D, Wallon D; PHRC GMAJ Collaborators..

Neurology. 2016 Aug 30;87(9):912-9. doi: 10.1212/WNL.0000000000003048. Epub 2016 Jul 27.

PMID:
27466472
11.

Gait Speed and Decline in Gait Speed as Predictors of Incident Dementia.

Dumurgier J, Artaud F, Touraine C, Rouaud O, Tavernier B, Dufouil C, Singh-Manoux A, Tzourio C, Elbaz A.

J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):655-661. doi: 10.1093/gerona/glw110.

PMID:
27302701
12.

Telemedicine for the acute management of stroke in Burgundy, France: an evaluation of effectiveness and safety.

Legris N, Hervieu-Bègue M, Daubail B, Daumas A, Delpont B, Osseby GV, Rouaud O, Giroud M, Béjot Y.

Eur J Neurol. 2016 Sep;23(9):1433-40. doi: 10.1111/ene.13054. Epub 2016 May 19.

PMID:
27194487
13.

Semantic memory assessment in 15 patients with amyotrophic lateral sclerosis.

Hervieu-Bègue M, Rouaud O, Graule Petot A, Catteau A, Giroud M.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):307-12. doi: 10.1016/j.neurol.2015.10.009. Epub 2016 May 4.

PMID:
27157419
14.

ADL disability and death in dementia in a French population-based cohort: New insights with an illness-death model.

Delva F, Touraine C, Joly P, Edjolo A, Amieva H, Berr C, Rouaud O, Helmer C, Pérès K, Dartigues JF.

Alzheimers Dement. 2016 Aug;12(8):909-16. doi: 10.1016/j.jalz.2016.03.007. Epub 2016 Apr 19.

PMID:
27103260
15.

ABCA7 rare variants and Alzheimer disease risk.

Le Guennec K, Nicolas G, Quenez O, Charbonnier C, Wallon D, Bellenguez C, Grenier-Boley B, Rousseau S, Richard AC, Rovelet-Lecrux A, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Pasquier F, Rollin-Sillaire A, Génin E, Lambert JC, Hannequin D, Campion D; CNR-MAJ collaborators..

Neurology. 2016 Jun 7;86(23):2134-7. doi: 10.1212/WNL.0000000000002627. Epub 2016 Apr 1.

PMID:
27037229
16.

The Clock'N Test as a Possible Measure of Emotions: Normative Data Collected on a Non-clinical Population.

Gros A, Manera V, Daumas A, Guillemin S, Rouaud O, Martin ML, Giroud M, Béjot Y.

Front Behav Neurosci. 2016 Feb 5;10:8. doi: 10.3389/fnbeh.2016.00008. eCollection 2016.

17.

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.

Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group..

Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005. Epub 2016 Feb 10.

PMID:
26876309
18.

Mental Rotation as an Indicator of Motor Representation in Patients with Mild Cognitive Impairment.

Bourrelier J, Kubicki A, Rouaud O, Crognier L, Mourey F.

Front Aging Neurosci. 2015 Dec 23;7:238. doi: 10.3389/fnagi.2015.00238. eCollection 2015.

19.

Vitamin K Antagonists and Cognitive Function in Older Adults: The Three-City Cohort Study.

Ferland G, Feart C, Presse N, Lorrain S, Bazin F, Helmer C, Berr C, Annweiler C, Rouaud O, Dartigues JF, Fourrier-Reglat A, Barberger-Gateau P.

J Gerontol A Biol Sci Med Sci. 2016 Oct;71(10):1356-62. doi: 10.1093/gerona/glv208. Epub 2015 Nov 17.

PMID:
26576841
20.

Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.

Jacquin-Piques A, Sacco G, Tavassoli N, Rouaud O, Bejot Y, Giroud M, Robert P, Vellas B, Bonin-Guillaume S.

J Alzheimers Dis. 2016;49(3):671-80. doi: 10.3233/JAD-150280.

PMID:
26484903

Supplemental Content

Loading ...
Support Center